IL6 and colorectal carcinoma: Additionally, CRC tumorigenesis appears to be sustained by inflammation, as seen in conditions such as inflammatory bowel disease, and CRC further releases inflammatory cytokines such as IL-6 to increase blood flow and tumor growth and evade immunity [13,14].